Vertex Pharmaceuticals Inc(VRTX)
291.59
Change: -10.12 (▼ -3.47%)
As of Tue 12/20/2022 01:16 PM% Of Value
Growth
Value Per Share
:
:
:
226.30
22.06
81.2700 (as of 19/12/2022)
Fundamentals Data
| Open | 301.55 | Dividend | 245 |
| Close Price | 291.59 | DivYield | 0 % |
| High | 302.59 | Growth | 1.3 B |
| Low | 289.48 | Growth% | 22.06 |
| P/e | 22.586 | Volume | 1.6 M |
| P/b | -1.13 | Market Capital | 75.8 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 307.84 (as of 20/12/2022) | 50 Days Moving Average Percentage | 0.18223086900132 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 2.4 B | 3.0 B | 4.1 B | 6.2 B | 7.5 B |
| Cap Spending | -99.4 M | -95.5 M | -75.4 M | -259.7 M | -235.0 M |
| Operating Expenses | 2.0 B | 2.0 B | 2.4 B | 2.5 B | 3.8 B |
| Operating Cash Flow | 123.2 M | 635.1 M | 1.2 B | 2.8 B | 2.7 B |
| Free Cash Flow | 745.5 M | 1.1 B | 1.4 B | 2.9 B | 2.4 B |
| Free Cash Flow Per Share | 2.996 | 4.62 | 5.819 | 11.521 | 9.346 |
| Total liabilities | 606.4 M | 591.3 M | 538.5 M | 889.5 M | 887.2 M |
| Total cash | 1.6 B | 2.6 B | 3.1 B | 5.9 B | 6.7 B |
| ROE% | 0.151 | 0.675 | 0.223 | 0.352 | 0.248 |
| Outstanding Shares | 253.8 M | 255.6 M | 259.2 M | 259.9 M | 254.5 M |
| P/E | 155.081 | 22.586 | 52.895 | 20.18 | 26.548 |
| P/S | 16.419 | 15.54 | 14.953 | 8.818 | 8.209 |
| Revenue USD | 2.4 B | 3.0 B | 4.1 B | 6.2 B | 7.5 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|